1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Stroke Diagnostics and Therapeutics: Global Markets

Stroke Diagnostics and Therapeutics: Global Markets

  • March 2015
  • -
  • BCC Research
  • -
  • 161 pages

REPORT HIGHLIGHTS

The global stroke management market was valued at $19.2 billion in 2013 and nearly $20.2 billion in 2014. This market is expected to reach nearly $28.3 billion by 2019, with a compound annual growth rate (CAGR) of 7% from 2014 to 2019.

This report provides:

An overview of the global market for stroke therapeutics and diagnostics.
Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
Information on the major factors driving and inhibiting growth of the global stroke diagnostics market and its products.
Identification and analysis of key market issues, trends, gaps, and opportunities within the market as well the market's sub-segments.
Comprehensive profiles of key companies and their product portfolios, and recent developments.

SCOPE OF THE REPORT

The report on global stroke diagnostics and management products market includes forecasts, trends and estimated sales through 2019. The report discusses in detail the market dynamics and the level of impact, key geographies and respective trends, competitive scenario that would form the base data for qualitative analysis and market estimates.
The global stroke diagnostics and management products market has been analyzed for the four main geographies of North America, Europe, Asia-Pacific and ROW. Given that the facilities available to patients vary depending on geography this is likely to have a direct impact on potential markets.

The report will discuss the various techniques used for stroke diagnostics (e.g. diagnostics imaging and magnetic resonance imaging) in detail. It will also analyze the therapeutic management of stroke (e.g. pharmacologic therapeutic modalities, stroke-related surgical and endovascular interventions). The discussions will mostly focus on what these techniques entail, expected volumes and innovations. In addition, the report investigates the various stroke management products — and how they are associated with the patient’s medical condition — and will focus on different types of products (e.g. computed tomography systems, diagnostic ultrasound systems) and related market forecasts and competitive analysis.

Table Of Contents

Stroke Diagnostics and Therapeutics: Global Markets

Chapter - 1: INTRODUCTION - Complimentary 4

STUDY AND OBJECTIVE
STUDY BACKGROUND
SCOPE OF THE REPORT
INTENDED AUDIENCE
SOURCE OF INFORMATION AND METHODOLOGY
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter - 2: EXECUTIVE SUMMARY 3

Table Summary : GLOBAL STROKE MANAGEMENT MARKET, THROUGH 2019
Figure Summary : GLOBAL STROKE MANAGEMENT MARKET, 2013-2019

Chapter - 3: MARKET OVERVIEW 53

STROKE AND CLASSIFICATION OF STROKE
INCIDENCE AND PREVALENCE RATES
CLINICAL DIAGNOSIS OF STROKE
THERAPEUTIC INTERVENTION
TECHNOLOGY DEVELOPMENTS - ROLE OF BIOMARKERS, RISK PREDICTION AND DIAGNOSIS
SUPPLY CHAIN PROCESS AND MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS: DEVELOPED VERSUS DEVELOPING ECONOMIES
REGULATIONS, GOVERNMENT POLICIES, ENVIRONMENT CLEARANCES, CE MARK/FDA APPROVALS ETC
CASE STUDIES AND BRIEF: EMERGING DEVICE-BASED ENDOVASCULAR THERAPIES
MARKET INTELLIGENCE
MARKET DYNAMICS
EMERGING ENDOVASCULAR THERAPEUTIC SYSTEMS
CURRENT SCENARIO AND FUTURE TRENDS
ANALYSIS, CONCLUSIONS AND RECOMMENDATIONS

Chapter - 4: STROKE DIAGNOSTIC AND MANAGEMENT DEVICES MARKET 17

STROKE DIAGNOSTICS

Chapter - 5: THERAPEUTIC MANAGEMENT OF STROKE 24

ANTICOAGULATION THERAPY
ANTIHYPERTENSIVE DRUG THERAPY
ANTIPLATELET DRUG THERAPY
OTHER DRUG THERAPIES
KEY STROKE MANAGEMENT DRUGS (GENERIC) ANALYSIS
STROKE-RELATED SURGICAL AND ENDOVASCULAR INTERVENTIONS
Table 39 : GLOBAL THERAPEUTIC MANAGEMENT MARKET OF STROKE BY DRUG CATEGORY, THROUGH 2019

Chapter - 6: MARKET BY TYPES OF STROKES 8

HEMORRHAGIC
ISCHEMIC
Table 73 : GLOBAL STROKES MARKET BY TYPE, THROUGH 2019

Chapter - 7: STROKE MANAGEMENT MARKET BY STAKEHOLDERS 8

SUPPLY CHAIN MEMBERS
END-USERS

Chapter - 8: COMPETITIVE LANDSCAPE 6

CERTIFICATION
PRODUCT LAUNCH
Figure 11 : RECENT DEVELOPMENT BY STRATEGIES, 2011 TO 2014

Chapter - 9: GEOGRAPHIC ANALYSIS 6

NORTH AMERICA
EUROPE
ASIA
REST OF THE WORLD

Chapter - 10: PATENT ANALYSIS 8

U.S. PATENT ANALYSIS
EUROPEAN PATENT ANALYSIS
JAPAN PATENT ANALYSIS
Figure 14 : GLOBAL PATENTS BY COMPANY, 2008 TO 2014

Chapter - 11: COMPANY PROFILES 14

ABBOTT VASCULAR
B BRAUN MELSUNGEN AG
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB
COAXIA INC.
CORDIS CORP.
GE HEALTHCARE
GENENTECH INC.
GLAXOSMITHKLINE PLC.
MERCK and COMPANY
MIZUHO AMERICA INC.
PHILIPS HEALTHCARE
SIEMENS HEALTHCARE

Chapter - 12: APPENDIX 10

UNITED STATES
EUROPE
JAPAN

List of Tables

Summary Table : GLOBAL STROKE MANAGEMENT MARKET, THROUGH 2019
Table 1 : RISK FACTORS OF STROKE
Table 2 : PREVALENCE OF STROKE IN THE U.K. BY REGION AND GENDER, 2010
Table 3 : TOTAL NUMBER OF DEATHS FROM STROKE IN THE U.K. BY REGION, 2010
Table 4 : ROLE OF BIOMARKERS
Table 5 : BIOMARKERS FOR SPECIFIC STROKE SUBTYPES
Table 6 : ADVANTAGES AND DISADVANTAGES OF BIOMARKERS BY TYPE
Table 7 : POST STROKE DISEASE MANAGEMENT - CLINICAL TRIAL
Table 8 : CLINICAL TRIAL: A SELF-EFFICACY ENHANCING STROKE SELF-MANAGEMENT PROGRAM FOR COMMUNITY-DWELLING STROKE SURVIVORS (SESSMP)
Table 9 : CLINICAL TRIAL: ADAPTIVE PHYSICAL ACTIVITY FOR CHRONIC STROKE
Table 10 : CLINICAL TRIAL: TAILORED APPROACHES TO STROKE HEALTH EDUCATION (TASHE)
Table 11 : CLINICAL TRIAL: PROSPECTIVE STROKE COHORT
Table 12 : HEALTHCARE EXPENDITURE COMPARISON, DEVELOPED VERSUS DEVELOPING ECONOMIES, 2008-2012*
Table 13 : GLOBAL STROKE DIAGNOSTIC IMAGING MARKET, THROUGH 2019
Table 14 : GLOBAL STROKE DIAGNOSTIC IMAGING MARKET BY REGION, THROUGH 2019
Table 15 : GLOBAL COMPUTED TOMOGRAPHY MARKET BY SYSTEM, THROUGH 2019
Table 16 : GLOBAL COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019
Table 17 : GLOBAL SPIRAL COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019
Table 18 : GLOBAL MULTISLICE COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019
Table 19 : GLOBAL DUAL SOURCE MULTISLICE COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019
Table 20 : GLOBAL COMPUTED TOMOGRAPHY ANGIOGRAPHY MARKET BY REGION, THROUGH 2019
Table 21 : GLOBAL PERFUSION COMPUTED TOMOGRAPHY MARKET BY REGION, THROUGH 2019
Table 22 : GLOBAL MRI MARKET BY TYPES, THROUGH 2019
Table 23 : GLOBAL MRI MARKET BY REGION, THROUGH 2019
Table 24 : GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET BY REGION, THROUGH 2019
Table 25 : GLOBAL TOF-MRA MARKET BY REGION, THROUGH 2019
Table 26 : GLOBAL PC-MRA MARKET BY REGION, THROUGH 2019
Table 27 : GLOBAL CE-MRA MARKET BY REGION, THROUGH 2019
Table 28 : GLOBAL FMRI MARKET BY REGION, THROUGH 2019
Table 29 : GLOBAL PROTON MAGNETIC RESONANCE SPECTROSCOPY MARKET BY REGION, THROUGH 2019
Table 30 : GLOBAL DIAGNOSTIC ULTRASOUND MARKET, THROUGH 2019
Table 31 : GLOBAL DIAGNOSTIC ULTRASOUND MARKET BY REGION, THROUGH 2019
Table 32 : GLOBAL DOPPLER ULTRASOUND MARKET BY REGION, THROUGH 2019
Table 33 : GLOBAL DUPLEX ULTRASOUND MARKET BY REGION, THROUGH 2019
Table 34 : GLOBAL CEREBRAL ANGIOGRAPHY MARKET BY REGION, THROUGH 2019
Table 35 : GLOBAL NUCLEAR IMAGING MARKET, THROUGH 2019
Table 36 : GLOBAL NUCLEAR IMAGING MARKET BY REGION, THROUGH 2019
Table 37 : GLOBAL GAMMA CAMERA IMAGING MARKET BY REGION, THROUGH 2019
Table 38 : GLOBAL PET MARKET BY REGION, THROUGH 2019
Table 39 : GLOBAL THERAPEUTIC MANAGEMENT MARKET OF STROKE BY DRUG CATEGORY, THROUGH 2019
Table 40 : GLOBAL ANTICOAGULATION THERAPY MARKET BY REGION, THROUGH 2019
Table 41 : GLOBAL ANTIHYPERTENSIVE DRUG THERAPY MARKET BY REGION, THROUGH 2019
Table 42 : GLOBAL ANTIPLATELET DRUG THERAPY MARKET BY REGION, THROUGH 2019
Table 43 : GLOBAL OTHER DRUG THERAPY MARKET BY REGION, THROUGH 2019
Table 44 : GLOBAL STROKE MANAGEMENT DRUG MARKET, THROUGH 2019
Table 45 : GLOBAL WARFARIN MARKET BY REGION, THROUGH 2019
Table 46 : GLOBAL DABIGATRAN MARKET BY REGION, THROUGH 2019
Table 47 : GLOBAL NADROPERIN MARKET BY REGION, THROUGH 2019
Table 48 : GLOBAL ENAXOPERIN MARKET BY REGION, THROUGH 2019
Table 49 : GLOBAL ATENOLOL MARKET BY REGION, THROUGH 2019
Table 50 : GLOBAL METOPROLOL MARKET BY REGION, THROUGH 2019
Table 51 : GLOBAL PINDOLOL MARKET BY REGION, THROUGH 2019
Table 52 : GLOBAL HYDROCHLOROTHIAZIDE MARKET BY REGION, THROUGH 2019
Table 53 : GLOBAL LOSARTAN MARKET BY REGION, THROUGH 2019
Table 54 : GLOBAL ENALAPRIL MARKET BY REGION, THROUGH 2019
Table 55 : GLOBAL LISINOPRIL MARKET BY REGION, THROUGH 2019
Table 56 : GLOBAL FELODIPINE MARKET BY REGION, THROUGH 2019
Table 57 : GLOBAL ASPIRIN MARKET BY REGION, THROUGH 2019
Table 58 : GLOBAL DIPYRIDAMOLE MARKET BY REGION, THROUGH 2019
Table 59 : GLOBAL CLOPIDOGREL MARKET BY REGION, THROUGH 2019
Table 60 : GLOBAL STROKE RELATED SURGICAL AND ENDOVASCULAR INTERVENTIONS MARKET, THROUGH 2019
Table 61 : GLOBAL STROKE RELATED SURGICAL AND ENDOVASCULAR INTERVENTIONS MARKET BY REGION, THROUGH 2019
Table 62 : GLOBAL STROKE-PRONE CAROTID ARTERY STENOSIS MARKET, THROUGH 2019
Table 63 : GLOBAL STROKE-PRONE CAROTID ARTERY STENOSIS MARKET BY REGION, THROUGH 2019
Table 64 : GLOBAL CAROTID ENDARTERECTOMY MARKET BY REGION, THROUGH 2019
Table 65 : GLOBAL CAROTID ARTERY STENTING MARKET BY REGION, THROUGH 2019
Table 66 : GLOBAL INTRACRANIAL ANEURYSMS AND ARTERIOVENOUS MALFORMATIONS MARKET, THROUGH 2019
Table 67 : GLOBAL INTRACRANIAL ANEURYSMS AND ARTERIOVENOUS MALFORMATIONS MARKET BY REGION, THROUGH 2019
Table 68 : GLOBAL INTRACRANIAL ANEURYSMS MARKET BY REGION, THROUGH 2019
Table 69 : GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET BY REGION, THROUGH 2019
Table 70 : GLOBAL SURGICAL REPAIR MARKET BY REGION, THROUGH 2019
Table 71 : GLOBAL ENDOVASCULAR EMBOLIZATION MARKET BY REGION, THROUGH 2019
Table 72 : GLOBAL STEREOTACTIC RADIOTHERAPY MARKET BY REGION, THROUGH 2019
Table 73 : GLOBAL STROKES MARKET BY TYPE, THROUGH 2019
Table 74 : GLOBAL HEMORRHAGIC STROKES MARKET BY TYPE, THROUGH 2019
Table 75 : GLOBAL HEMORRHAGIC STROKES MARKET BY REGION, THROUGH 2019
Table 76 : GLOBAL INTRACEREBRAL STROKES MARKET BY REGION, THROUGH 2019
Table 77 : GLOBAL SUBARACHNOID HEMORRHAGE STROKES MARKET BY REGION, THROUGH 2019
Table 78 : GLOBAL ISCHEMIC STROKES MARKET, THROUGH 2019
Table 79 : GLOBAL ISCHEMIC STROKES MARKET BY REGION, THROUGH 2019
Table 80 : GLOBAL THROMBOTIC STROKES MARKET BY REGION, THROUGH 2019
Table 81 : GLOBAL EMBOLIC STROKES MARKET BY REGION, THROUGH 2019
Table 82 : GLOBAL TRANSIENT ISCHEMIC ATTACK MARKET BY REGION, THROUGH 2019
Table 83 : GLOBAL STROKE MANAGEMENT MARKET BY SUPPLY CHAIN MEMBERS, THROUGH 2019
Table 84 : GLOBAL STROKE MANAGEMENT MARKET-MANUFACTURERS, BY REGION, THROUGH 2019
Table 85 : GLOBAL STROKE MANAGEMENT MARKET-DISTRIBUTORS, BY REGION, THROUGH 2019
Table 86 : GLOBAL STROKE MANAGEMENT MARKET-SUPPLIERS, BY REGION, THROUGH 2019
Table 87 : GLOBAL STROKE MANAGEMENT MARKET BY END USERS, THROUGH 2019
Table 88 : GLOBAL STROKE MANAGEMENT MARKET-LIFE SCIENCES, BY REGION, THROUGH 2019
Table 89 : GLOBAL STROKE MANAGEMENT MARKET-HOSPITALS, BY SIZE, THROUGH 2019
Table 90 : GLOBAL STROKE MANAGEMENT MARKET-HOSPITALS, BY REGION, THROUGH 2019
Table 91 : GLOBAL STROKE MANAGEMENT MARKET-DIAGNOSTIC CENTERS, BY REGION, THROUGH 2019
Table 92 : GLOBAL STROKE MANAGEMENT MARKET-PATIENTS, BY REGION, THROUGH 2019
Table 93 : RECENT DEVELOPMENT - CERTIFICATION BY COMPANY, 2011 TO 2014
Table 94 : RECENT DEVELOPMENT-PRODUCT LAUNCH BY COMPANY, 2011 TO 2014
Table 95 : NORTH AMERICAN STROKE MANAGEMENT MARKET, THROUGH 2019
Table 96 : EUROPE GERIATRIC POPULATION STATISTICS, 1991 AND 2011
Table 97 : EUROPEAN STROKE MANAGEMENT MARKET, THROUGH 2019
Table 98 : ASIA GERIATRIC POPULATION STATISTICS, 2000 AND 2025
Table 99 : ASIAN STROKE MANAGEMENT MARKET, THROUGH 2019
Table 100 : ROW STROKE MANAGEMENT MARKET, THROUGH 2019
Table 101 : ABBOTT VASCULAR'S PRODUCT PORTFOLIO
Table 102 : ABBOTT VASCULAR'S RECENT DEVELOPMENTS, 2011 TO AUG 2014
Table 103 : B BRAUN'S PRODUCT PORTFOLIO
Table 104 : BOSTON SCIENTIFIC'S PRODUCT PORTFOLIO
Table 105 : BOSTON SCIENTIFIC'S RECENT DEVELOPMENTS, 2011 TO JUNE 2014
Table 106 : BRISTOL MYERS SQUIBB PRODUCT PORTFOLIO
Table 107 : BRISTOL MYERS SQUIBB RECENT DEVELOPMENTS - 2011 TO SEP 2014
Table 108 : COAXIA INC PRODUCT PORTFOLIO
Table 109 : CORDIS CORP. PRODUCT PORTFOLIO
Table 110 : GE HEALTHCARE PRODUCT PORTFOLIO
Table 111 : GE HEALTHCARE RECENT DEVELOPMENTS, 2011 TO AUG 2014
Table 112 : GENENTECH'S PRODUCT PORTFOLIO
Table 113 : GLAXOSMITHKLINE PLC PRODUCT PORTFOLIO
Table 114 : MERCK'S PRODUCT PORTFOLIO
Table 115 : MERCK'S RECENT DEVELOPMENTS 2011 TO SEP 2014
Table 116 : MIZUHO AMERICA'S PRODUCT PORTFOLIO
Table 117 : PHILIPS HEALTHCARE PRODUCT PORTFOLIO
Table 118 : PHILIPS HEALTHCARE RECENT DEVELOPMENTS, 2011 TO APRIL 2014
Table 119 : SIEMENS HEALTHCARE'S PRODUCT PORTFOLIO
Table 120 : U.S. PATENT LIST, 2011 TO 2014
Table 121 : EUROPEAN PATENT LIST, 2011 TO 2014
Table 122 : JAPAN PATENT LIST, 2011 TO 2014
List of Figures
Summary Figure : GLOBAL STROKE MANAGEMENT MARKET, 2013-2019
Figure 1 : TOP 10 LEADING CAUSES OF DEATH IN THE WORLD, 2012
Figure 2 : NUMBER OF STROKES IN THE WORLD, 1990-2010
Figure 3 : GLOBAL INCIDENCE AND PREVALENCE OF STROKE BY REGION, 2010
Figure 4 : U.S. PREVALENCE OF STROKE BY AGE AND GENDER IN PERCENTAGE OF POPULATION, 2010
Figure 5 : ALGORITHM FOR THE DIAGNOSIS OF ACUTE STROKE
Figure 6 : SUPPLY CHAIN ANALYSIS - STROKE DIAGNOSIS AND MANAGEMENT
Figure 7 : FACTORS THAT INFLUENCE THE QUALITY OF THE STROKE MANAGEMENT SUPPLY CHAIN
Figure 8 : TIMELINE FOR ENACTMENT OF PRIMARY STROKE CENTER LEGISLATIVE OR NON-LEGISLATIVE POLICY, JULY 2010
Figure 9 : RECENT DEVELOPMENTS BY COMPANY, 2011-2014
Figure 10 : GLOBAL POPULATION GROWTH, BY AGE GROUP, 2010-2020
Figure 11 : RECENT DEVELOPMENT BY STRATEGIES, 2011 TO 2014
Figure 12 : CERTIFICATION BY COMPANIES, 2011 TO 2014
Figure 13 : PRODUCT LAUNCH BY COMPANIES, 2011 TO 2014
Figure 14 : GLOBAL PATENTS BY COMPANY, 2008 TO 2014
Figure 15 : U.S. PATENTS BY TECHNOLOGY, 2008 TO 2014
Figure 16 : U.S. PATENTS BY COMPANY, 2008 TO 2014
Figure 17 : EUROPEAN PATENTS BY TECHNOLOGY, 2008 TO 2014
Figure 18 : EUROPEAN PATENTS BY COMPANY, 2008 TO 2014
Figure 19 : JAPAN PATENTS BY TECHNOLOGY, 2008 TO 2014
Figure 20 : JAPAN PATENTS BY COMPANY, 2008 TO 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
North America And Europe Stroke Diagnostics Market Analysis By Technology, By Region And Segment Forecasts To 2024

North America And Europe Stroke Diagnostics Market Analysis By Technology, By Region And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The North America and Europe stroke diagnostics market is expected to reach USD 1.4 million by 2024, according to a new report by Grand View Research Inc. The stroke diagnostics market is anticipated to ...

Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

Acute ischemic stroke (AIS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

Global In Vitro Diagnostics 2010-2016: Deal trends, players, financials and forecasts

  • $ 2995
  • Industry report
  • November 2016
  • by Currentpartnering

The Global In Vitro Diagnostics Partnering 2010-2016 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.